These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26666942)

  • 1. Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.
    Nyunt MM; Nguyen VK; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Mwima MW; Achan J; Aweeka F; Parikh S; Mwebaza N
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1274-82. PubMed ID: 26666942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
    McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F
    PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
    Tarning J; McGready R; Lindegardh N; Ashley EA; Pimanpanarak M; Kamanikom B; Annerberg A; Day NP; Stepniewska K; Singhasivanon P; White NJ; Nosten F
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3837-46. PubMed ID: 19564366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
    McGready R; Stepniewska K; Lindegardh N; Ashley EA; La Y; Singhasivanon P; White NJ; Nosten F
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1021-31. PubMed ID: 17053895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
    Tarning J; Kloprogge F; Dhorda M; Jullien V; Nosten F; White NJ; Guerin PJ; Piola P
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5096-103. PubMed ID: 23917320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.
    Mosha D; Guidi M; Mwingira F; Abdulla S; Mercier T; Decosterd LA; Csajka C; Genton B
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4583-92. PubMed ID: 24867986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
    Tarning J; Kloprogge F; Piola P; Dhorda M; Muwanga S; Turyakira E; Nuengchamnong N; Nosten F; Day NP; White NJ; Guerin PJ; Lindegardh N
    Malar J; 2012 Aug; 11():293. PubMed ID: 22913677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
    Hietala SF; Mårtensson A; Ngasala B; Dahlström S; Lindegårdh N; Annerberg A; Premji Z; Färnert A; Gil P; Björkman A; Ashton M
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4780-8. PubMed ID: 20713675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
    Tchaparian E; Sambol NC; Arinaitwe E; McCormack SA; Bigira V; Wanzira H; Muhindo M; Creek DJ; Sukumar N; Blessborn D; Tappero JW; Kakuru A; Bergqvist Y; Aweeka FT; Parikh S
    J Infect Dis; 2016 Oct; 214(8):1243-51. PubMed ID: 27471317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
    Tiono AB; Tinto H; Alao MJ; Meremikwu M; Tshefu A; Ogutu B; Ouedraogo A; Lingani M; Cousin M; Lefèvre G; Jain JP; Duparc S; Hamed K
    Malar J; 2015 Apr; 14():157. PubMed ID: 25886021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.
    Mutagonda RF; Kamuhabwa AAR; Minzi OMS; Massawe SN; Asghar M; Homann MV; Färnert A; Aklillu E
    Malar J; 2017 Jul; 16(1):267. PubMed ID: 28673292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
    Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.
    Ukah M; Badejoko O; Ogunniyi S; Loto O; Aboderin O; Fatusi A
    Int J Gynaecol Obstet; 2015 Oct; 131(1):41-4. PubMed ID: 26169336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
    ; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
    N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria.
    Lohy Das J; Rulisa S; de Vries PJ; Mens PF; Kaligirwa N; Agaba S; Tarning J; Karlsson MO; Dorlo TPC
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study.
    Hatz C; Soto J; Nothdurft HD; Zoller T; Weitzel T; Loutan L; Bricaire F; Gay F; Burchard GD; Andriano K; Lefèvre G; De Palacios PI; Genton B
    Am J Trop Med Hyg; 2008 Feb; 78(2):241-7. PubMed ID: 18256423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.
    Kaye DK; Nshemerirwe R; Mutyaba TS; Ndeezi G
    J Infect Dev Ctries; 2008 Apr; 2(2):135-9. PubMed ID: 19738339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
    Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia.
    Jima D; Tesfaye G; Medhin A; Kebede A; Argaw D; Babaniyi O
    East Afr Med J; 2005 Aug; 82(8):387-90. PubMed ID: 16261913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.